NCT05732792

Brief Summary

Impostor syndrome is a form of erroneous self-assessment that is defined as the inability to believe that one's success is earnt and that positive outcomes are the result of one's skills. The syndrome has been described and studied in an array of different populations including the healthcare setting and academic faculty members working in a competitive environment. A scoping review of the imposter syndrome in physicians and physicians in training concluded that low self-esteem, gender, and institutional culture are linked to high rates of imposter syndrome. The fact that this syndrome has been linked to higher rates of burnout is more worrisome. Moreover, this specific syndrome might prevent physicians from acting in certain situations. Even though Impostor syndrome has been described in doctors across a wide range of specialties, it has yet to be specifically investigated within anesthesiology. We hypothesize that imposter syndrome prevalence will be high in this population due to core attributes of the profession itself. With this study, the prevalence and severity of imposter syndrome in the European anesthesia profession will be investigated by using the Clance Impostor Phenomenon Scale (CIPS) scale, which will be completed by anesthesiologists and anesthesiology residents members of the European Society of Anesthesiology and Intensive Care. In parallel, key demographics that are linked to increased severity of the imposter syndrome will also be investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
700

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

February 11, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 17, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 11, 2023

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 14, 2023

Completed
Last Updated

July 21, 2023

Status Verified

July 1, 2023

Enrollment Period

3 months

First QC Date

February 8, 2023

Last Update Submit

July 20, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • CIPS

    The primary aim of this study is to define the prevalence and severity of imposter syndrome among anesthesiologists, which has never been evaluated on a large scale. This will be done through CIPS (Clance Imposter Phenomenon Scale) score. (CIPS is a previously validated survey consisting of 20 questions on a 5-point Likert scale that investigate feelings about self-assessment of competency, praise, and success. Levels of severity of imposter syndrome have been described previously. Briefly, if the total score is 40 or less, the respondent has few Impostor characteristics; if the score is between 41 and 60, the respondent has moderate IP experiences; a score between 61 and 80 means the respondent frequently has Impostor feelings; a score higher than 80 means the respondent often has intense IP experiences. The higher the score, the more frequently and seriously the Impostor Phenomenon interferes in a person's life.

    3 months

Secondary Outcomes (1)

  • Risk factors IP-anesthesia

    3 months

Study Arms (1)

Anesth-CIPS

The survey is endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC) and will be distributed from February 2023 onwards to its members for a period of 6 months.

Other: CIPS Survey

Interventions

The survey is endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC) and will be distributed from February 2023 onwards to its members for a period of 3 months. Each anesthesiologist's participation to the survey will be voluntary and anonymous individual consent will be implied by the person's willingness to complete the survey. The survey will also mention this. All surveys will be administered via SurveyMonkey. Surveymonkey allows to build "Health Insurance Portability and Accountability Act" (HIPAA) compliant surveys that follow strict rules around the protection of health information. Of note, Surveymonkey is also GDPR (General Data Protection Regulation) compliant. Data gathered from the questionnaires will be safely stored on the surveymonkey database. The access to the result database is held by a password that only the authors can use to analyze the data yielded at the end of the survey period.

Anesth-CIPS

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The survey is endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC) and will be distributed from February 2023 onwards to its members for a period of 3 months.

You may qualify if:

  • Anesthesiologists

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AZ Sint-Jan Brugge Oostende AV

Bruges, Belgium

Location

MeSH Terms

Conditions

imposter syndrome

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 8, 2023

First Posted

February 17, 2023

Study Start

February 11, 2023

Primary Completion

May 11, 2023

Study Completion

May 14, 2023

Last Updated

July 21, 2023

Record last verified: 2023-07

Locations